Chronic Obstructive Pulmonary Disease COPD
Conditions
Interventions
None listed
Sponsors
Universitair Medisch Centrum Groningen
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: •Written informed consent must be obtained before any assessment is performed. •Male and female patients >= 40 years of age •Diagnosis of COPD (GOLD criteria: post bronchodilator FEV1/FVC
Exclusion criteria
Exclusion criteria: •Orthopedic, neurological or other complaints that significantly impair normal biomechanical movement patterns, as judged by the investigator. Specifically if the patients* condition/ co-morbidities are such that physical activity cannot be increased. •Respiratory diseases other than COPD (e.g. asthma) •Cognitive reading impairment and/or difficulties to manage electronic devices precluding interaction with the healthbase and PDA, as judged by the investigator •Participating in or scheduled to start a rehabilitation program during the study. If the patient wishes to participate in pulmonary rehabilitation for any reason the patient can be enrolled in the study only at the end of rehabilitation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary objectives are: • To assess the impact of a physical activity promotion program on physical activity in patients with COPD in addition to usual care. This will be measured by the PROactive monitors (ActiGraph® and DynaPort®), as the change in average daily number of steps at baseline (during the week prior to visit 101) and at the end of the 3-month epoch (during the week prior to Visit 102). • To assess construct validity of the daily version of PROactive instrument and its responsiveness to a telecoaching program in addition to usual care in COPD patients. | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary objectives are to assess change from baseline to 3 months between the intervention group and the control group in: 1-Time spent in at least moderate physical activity 2- Proportion of patients showing an increase of physical activity by >20% 3- Exercise capacity (6-minute walking test (6MWT); Incremental shuttle walk test (ISWT) in a subset of mild patients) 4- Muscle strength (as measured by quadriceps maximal volitional contraction) 5- COPD symptoms and health-related quality of life (as measured by the CAT, CCQ, HADS, mMRC and SGRQ-C) 6- Change from baseline to 3 months between the intervention group and the control group in average daily number of steps 7- Satisfaction with the coaching system | — |
Countries
Netherlands
Outcome results
None listed